Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NAAA inhibitors(N acylethanolamine acid amidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H27N5O4S |
InChIKeyFVIHLKFGYOKIDE-FVQHAEBGSA-N |
CAS Registry2320521-34-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | IT | 01 Sep 2021 |